1![Hematology Division Introduction In the past, the Hematology Division had made important discoveries in a number of lymphoid malignancies including adult T-cell leukemia-lymphoma (ATL) and angioimmunoblastic T-cell lymph Hematology Division Introduction In the past, the Hematology Division had made important discoveries in a number of lymphoid malignancies including adult T-cell leukemia-lymphoma (ATL) and angioimmunoblastic T-cell lymph](https://www.pdfsearch.io/img/7c98d979d2f3e1a3e6f312f03586924b.jpg) | Add to Reading ListSource URL: www.ncc.go.jpLanguage: English - Date: 2014-03-30 02:23:20
|
---|
2![B07/S/dNHS STANDARD CONTRACT HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1 AND 2 (ALL AGES) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No. B07/S/dNHS STANDARD CONTRACT HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE 1 AND 2 (ALL AGES) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification No.](https://www.pdfsearch.io/img/7e1c0176caaeb36c53340eb859070880.jpg) | Add to Reading ListSource URL: www.england.nhs.ukLanguage: English - Date: 2013-08-13 12:10:40
|
---|
3![Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB Myocyte enhancer factor (MEF)-2 plays essential roles in T-cell transformation associated with HTLV-1 infection by stabilizing complex between Tax and CREB](https://www.pdfsearch.io/img/2e1f00d68833e69a1969df2fbfa39c78.jpg) | Add to Reading ListSource URL: www.retrovirology.comLanguage: English |
---|
4![OPEN Citation: Cell Death and Disease[removed], e1575; doi:[removed]cddis[removed] & 2014 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis OPEN Citation: Cell Death and Disease[removed], e1575; doi:[removed]cddis[removed] & 2014 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis](https://www.pdfsearch.io/img/a60bfbae27ec9696cab9a9c7e3229d74.jpg) | Add to Reading ListSource URL: www.nature.comLanguage: English - Date: 2014-12-18 08:42:50
|
---|
5![Human T-Cell Lymphotropic Virus type I Pro Viral Load Assay Stirling Dick NRL, Melbourne, Australia Human T-Cell Lymphotropic Virus type I Pro Viral Load Assay Stirling Dick NRL, Melbourne, Australia](https://www.pdfsearch.io/img/f96d796f44b71c5cb56bf81468df0c3a.jpg) | Add to Reading ListSource URL: www.nrl.gov.auLanguage: English - Date: 2014-12-14 17:07:22
|
---|
6![Case Report Human T-Cell Lymphotropic Virus Type 1 Myelopathy/Tropical Spastic Paraparesis in a 65-Year-Old Man Sandra A. Illum, MD Case Report Human T-Cell Lymphotropic Virus Type 1 Myelopathy/Tropical Spastic Paraparesis in a 65-Year-Old Man Sandra A. Illum, MD](https://www.pdfsearch.io/img/4173abac03e74e44e8c8ce9cded04e09.jpg) | Add to Reading ListSource URL: www.turner-white.comLanguage: English |
---|
7![Retrovirology BioMed Central Open Access Retrovirology BioMed Central Open Access](https://www.pdfsearch.io/img/fff2321ec893bf0dfac4b0b9fe9246e6.jpg) | Add to Reading ListSource URL: www.ncbi.nlm.nih.govLanguage: English |
---|
8![Guidance for Industry: Donor Screening for Antibodies to HTLV-II Guidance for Industry: Donor Screening for Antibodies to HTLV-II](https://www.pdfsearch.io/img/cf73f6878f5192f14ffe51211a82a9d1.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
9![Summary Basis for Regulatory Action: Human T-Lymphotropic Virus Types I & II Summary Basis for Regulatory Action: Human T-Lymphotropic Virus Types I & II](https://www.pdfsearch.io/img/4427bfa33870155a0365f8cffa68f882.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
10![HTLV-I (long latency; virus is not expressed in tumors) Lee Ratner MD PhD Director of Molecular Oncology Washington University School of Medicine HTLV-I (long latency; virus is not expressed in tumors) Lee Ratner MD PhD Director of Molecular Oncology Washington University School of Medicine](https://www.pdfsearch.io/img/3f39ce231e031ad9debb8e3b9749747d.jpg) | Add to Reading ListSource URL: osp.od.nih.govLanguage: English - Date: 2014-01-08 12:15:26
|
---|